ACE2 and coronary artery disorder: To the best of our knowledge, this study represents the first attempt to examine the immunohistochemical representation of ACE2 protein among different myocardial cells corresponding to ischemic heart disease-induced HF stages, namely A (at risk of HF), B (pre-HF), and C/D (symptomatic and advanced HF, respectively) [26].